Anti-IL-17A antibody and use thereof
US12209124B2 · kind B2 · utility
Assignees
Inventors
Key dates
| Filing date | Dec 11, 2019 |
| Grant date | Jan 28, 2025 |
| Priority date | — |
| Expiry date | May 18, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides an antibody or a functional fragment thereof that specifically binds to IL-17A with high affinity. Also provided are a nucleic acid molecule encoding the antibody or the functional fragment thereof disclosed herein, an expression vector and a host cell for expressing the antibody or the functional fragment thereof disclosed herein, and a method for preparing the antibody or the functional fragment thereof disclosed herein. The present invention also provides a pharmaceutical composition comprising the antibody or the functional fragment thereof disclosed herein, and use of the antibody or the functional fragment thereof disclosed herein for treating an immune dysfunction disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.